EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC 4.0

Magnitude of Hyperuricemia and Its Associated Factors Among People Living with Human Immunodeficiency Virus Who Enrolled in First-Line Antiretroviral Therapy in Amhara Region, Ethiopia

Mohammed Jemal iD, Desalegn Abebaw, Tabarak Malik, Muluken Getinet Mekuriaw, Dagmawi Abiy Abate, Temechew Munaw Abebe iD, Tilahun Bitew, Enatnesh Essa Osman, Adane Adugna

Journal of the International Association of Providers of AIDS Care (JIAPAC) · 2025

DOI: 10.1177/23259582251400988 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the International Association of Providers of AIDS Care (JIAPAC), 2025. Verfasst von Mohammed Jemal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, School of Medicine, Debre Markos University, Debre Markos, Ethiopia. Hauptthemen laut MEDLINE: Hyperuricemia, HIV Infections, Anti-HIV Agents. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In people living with human immunodeficiency virus (PLHIV), hyperuricemia may result from antiretroviral therapy (ART)-induced metabolic changes, lifestyle behaviors, and individual host factors. However, there is a scarcity of data on the prevalence and determinants of hyperuricemia among PLHIV on ART in sub-Saharan Africa.

Objective

This study aimed to assess the magnitude of hyperuricemia and its associated factors among PLHIV who enrolled in first-line ART in the Amhara Region, Ethiopia.

Method

A multi-center, institution-based cross-sectional study was conducted from March 15 to June 15, 2024. Referral hospitals were selected through simple random sampling, and a total of 401 participants were enrolled from these hospitals using a systematic sampling approach. Data were collected using a structured questionnaire, patient chart review, physical measurements, and biochemical analysis. Hyperuricemia was defined as a serum uric acid level is >6 mg/dL for females and >7 mg/dL for males. Multivariable logistic regression was employed to identify the factors that are associated with hyperuricemia, and a statistical significance was decided at P ≤ .05.

Result

The overall magnitude of hyperuricemia among PLHIV was 28.2% (95% confidence interval (CI): 23.7-32.5%). Male sex (AOR = 1.79, 95% CI: 1.07, 2.98), older age (AOR = 1.03; 95% CI: 1-1.06), obesity (AOR = 2.21; 95% CI: 1.04-4.73), and longer ART duration (AOR = 1.13; 95% CI: 1.01-1.27) were significantly associated with hyperuricemia.

Conclusion

Our study found a relatively high prevalence of hyperuricemia (28.2%) among PLHIV on first-line ART. Significant associated factors included male sex, older age, obesity, and longer ART duration. Therefore, early screening, particularly in males, older adults, those with obesity, and long-term ART users, is essential to prevent complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperuricemiaHIV InfectionsAnti-HIV AgentsHumansEthiopiaMaleFemaleCross-Sectional StudiesAdultMiddle AgedPrevalenceRisk FactorsYoung AdultUric AcidAdolescent

Stichwörter der Autor:innen

antiretroviral therapydolutegravirefavirenzhuman immunodeficiency virushyperuricemiapeople living with human immunodeficiency virus

Substanzen

Anti-HIV AgentsUric Acid

Autor:innen und Institutionen

  • Department of Biomedical Science, School of Medicine, Debre Markos University, Debre Markos, Ethiopia.
  • Department of Medical Laboratory Sciences, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia.
  • Department of Biomedical Sciences, Institute of Health, Jimma University, Jimma, Ethiopia.
  • Division of Research & Development, Lovely Professional University, Phagwara, Punjab, India.
  • Department of Pathology, School of Medicine, Debre Markos University, Debre Markos, Ethiopia.
  • Department of Biomedical Sciences, School of Medicine, Injibara University, Injibara, Ethiopia.

ORCID-Profile: Mohammed Jemal, Temechew Munaw Abebe

Zitieren

APA

Jemal, M., Abebaw, D., Malik, T., Mekuriaw, M. G., Abate, D. A., Abebe, T. M., Bitew, T., Osman, E. E., & Adugna, A. (2025). Magnitude of Hyperuricemia and Its Associated Factors Among People Living with Human Immunodeficiency Virus Who Enrolled in First-Line Antiretroviral Therapy in Amhara Region, Ethiopia. Journal of the International Association of Providers of AIDS Care (JIAPAC). https://doi.org/10.1177/23259582251400988

Vancouver

Jemal M, Abebaw D, Malik T, Mekuriaw MG, Abate DA, Abebe TM, et al. Magnitude of Hyperuricemia and Its Associated Factors Among People Living with Human Immunodeficiency Virus Who Enrolled in First-Line Antiretroviral Therapy in Amhara Region, Ethiopia. Journal of the International Association of Providers of AIDS Care (JIAPAC). 2025. doi:10.1177/23259582251400988

BibTeX
@article{Jemal2025,
  author = {Jemal, Mohammed and Abebaw, Desalegn and Malik, Tabarak and Mekuriaw, Muluken Getinet and Abate, Dagmawi Abiy and Abebe, Temechew Munaw and Bitew, Tilahun and Osman, Enatnesh Essa and Adugna, Adane},
  title = {Magnitude of Hyperuricemia and Its Associated Factors Among People Living with Human Immunodeficiency Virus Who Enrolled in First-Line Antiretroviral Therapy in Amhara Region, Ethiopia},
  journal = {Journal of the International Association of Providers of AIDS Care (JIAPAC)},
  year = {2025},
  doi = {10.1177/23259582251400988}
}
Kostenlos starten →